FIELD: medicine.
SUBSTANCE: level of circulating CD45+ is determined in blood test of patients and if value is 0.91% and higher of the total number of platelets, conclusion about presence of restenosis is made.
EFFECT: application of claimed method makes it possible to increase accuracy of restenosis development.
2 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR DEVELOPING STRICTURE FORMATION IN DRUG-COATED STENTS | 2011 |
|
RU2466403C1 |
METHOD FOR RESTENOSIS DEVELOPMENT PREDICTION IN PATIENTS WITH STABLE EXERTIONAL ANGINA FOLLOWING CORONARY STENTING | 2020 |
|
RU2724279C1 |
METHOD FOR PREDICTING DEVELOPMENT OF RESTENOSIS OF CORONARY ARTERY AFTER STENTING WITH BARE METAL OR DRUG-ELUTING STENT IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2748010C1 |
METHOD FOR PREDICTION OF ACUTE THROMBOSIS OR RESTENOSIS OF MAIN ARTERIES OF HEAD AFTER ENDOVASCULAR ANGIOPLASTY WITH STENTING | 2015 |
|
RU2595485C1 |
METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
METHOD FOR PREDICTING THROMBOSIS IN A CORONARY STENT WITH PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2662366C1 |
METHOD FOR FUNCTIONAL AND QUANTITATIVE EVALUATION OF PLATELET-MONOCYTIC COMPLEXES IN WHOLE PERIPHERAL BLOOD SAMPLES | 2020 |
|
RU2762820C1 |
METHOD FOR DETECTING TUMOUR CELLS CIRCULATING IN BLOOD BY MULTIPARAMETER FLOW CYTOMETRY | 2024 |
|
RU2825188C2 |
METHOD FOR FORECASTING THE ONE-YEAR RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS AFTER STENTING OF CORONARY ARTERIES IN PATIENTS WITH CORONARY HEART DISEASE WITH METABOLIC SYNDROME WITHOUT INSULIN RESISTANCE | 2017 |
|
RU2663496C1 |
METHOD FOR STENT RESTENOSIS PREDICTION IN PATIENTS WITH ISCHEMIC HEART DISEASE 6 MONTHS AFTER CORONARY STENTING | 2019 |
|
RU2695782C1 |
Authors
Dates
2015-10-20—Published
2014-03-20—Filed